Discover how helical sulfonyl-γ-AApeptides target LC3 in cancer cells to disrupt autophagy and create new cancer therapies.
Discover how synthetic Granzyme B molecules are revolutionizing targeted cancer therapy through the innovative COVERT platform.
Discover how inhibiting the 26S proteasome and K48-linked ubiquitination could revolutionize osteoarthritis treatment by targeting cellular waste management systems.
Discover how repeated eccentric exercise transforms rat skeletal muscle at the proteomic level, revealing the molecular basis of muscle adaptation and recovery.
Discover how murine Gbp1 and Gbp2 are ubiquitinated independently of Toxoplasma gondii infection, challenging our understanding of cellular defense mechanisms.
Discover how Nrf2 regulates Cereblon expression and influences clinical response to lenalidomide and erythropoietin combination therapy in lower-risk MDS.
Discover how GSK-3 inhibition affects DNA damage response through TopBP1 degradation and its potential for revolutionizing cancer therapy.
Discover how the ancient Chinese formula Gegen Qinlian Decoction protects against radiation-induced intestinal injury through modern scientific research and network pharmacology.
Discover how proteomics is revolutionizing liver cancer research by revealing protein-level dysfunction in hepatocellular carcinoma tissues.
Discover how PROTAC molecular technology is revolutionizing leukemia treatment by degrading cancer-causing proteins with unprecedented efficacy.